Jeewan C Ranasinghe1, Arpit Jain2, Wenjing Wu1, Kunyan Zhang1, Ziyang Wang1, Shengxi Huang1. 1. Department of Electrical Engineering, The Pennsylvania State University, University Park, PA 16802 USA. 2. Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802 USA.
Abstract
Two-dimensional (2D) layered materials as a new class of nanomaterial are characterized by a list of exotic properties. These layered materials are investigated widely in several biomedical applications. A comprehensive understanding of the state-of-the-art developments of 2D materials designed for multiple nanoplatforms will aid researchers in various fields to broaden the scope of biomedical applications. Here, we review the advances in 2D material-based biomedical applications. First, we introduce the classification and properties of 2D materials. Next, we summarize surface and structural engineering methods of 2D materials where we discuss surface functionalization, defect, and strain engineering, and creating heterostructures based on layered materials for biomedical applications. After that, we discuss different biomedical applications. Then, we briefly introduced the emerging role of machine learning (ML) as a technological advancement to boost biomedical platforms. Finally, the current challenges, opportunities, and prospects on 2D materials in biomedical applications are discussed.
Two-dimensional (2D) layered materials as a new class of nanomaterial are characterized by a list of exotic properties. These layered materials are investigated widely in several biomedical applications. A comprehensive understanding of the state-of-the-art developments of 2D materials designed for multiple nanoplatforms will aid researchers in various fields to broaden the scope of biomedical applications. Here, we review the advances in 2D material-based biomedical applications. First, we introduce the classification and properties of 2D materials. Next, we summarize surface and structural engineering methods of 2D materials where we discuss surface functionalization, defect, and strain engineering, and creating heterostructures based on layered materials for biomedical applications. After that, we discuss different biomedical applications. Then, we briefly introduced the emerging role of machine learning (ML) as a technological advancement to boost biomedical platforms. Finally, the current challenges, opportunities, and prospects on 2D materials in biomedical applications are discussed.
Over the past decade, nanoscience and nanotechnology have undergone significant advances in many interdisciplinary fields as more light is shed on its real-life applications with a special focus on biomedicine. Typically, nanomaterials are defined as a material of which dimension ranges from 1 to 100 nm creating an intermediate regime between atoms and bulk counterparts. 2D materials are especially desirable among various nanomaterials due to their layered structure with rich surface chemistry, establishing it as a hot research topic in the scientific community. 2D material can be generally described as a monolayer to a few-layered structure with a planar architecture [1-4]. Successful isolation of graphene back in 2004 followed by the synthesis of graphene-like 2D materials resulted in significant interest among researchers to explore the vibrant area of 2D materials which is applicable in biomedical applications [5-9].The family of 2D materials includes graphene, hexagonal boron nitride (h-BN), transition metal dichalcogenides (TMDs), black phosphorous (BP), MXenes, etc. What makes 2D materials an exciting class of nanomaterial toward the biomedical field is their fascinating properties as compared to their bulk counterparts. 2D materials are especially attractive for biomedical applications as a consequence of their structure, large surface area, transport properties, ease of functionalization, biocompatibility, and adsorption capabilities, to name a few. Notably, 2D materials exhibit unique optical, mechanical, electrical, and magnetic properties that can be utilized in biomedical applications [10-15]. To unlock the true potential of 2D materials, scientists need to explore different avenues of synthesis, characterization, and applications of these materials. Although layered materials behold many merits, material properties can be modulated via the engineering of 2D materials to further enhance the sensing performances. In this regard, surface functionalization, defect and strain engineering, and creating 2D material-based heterostructures are explored as key-engineering pathways. As an artificial intelligent method, ML can provide insights into the synthesizability of 2D materials and the discovery of new materials by the means of structure–property relationships. In addition, ML has a critical role in analyzing raw sensing data by categorization, anomaly detection, noise reduction, target identification, and pattern recognition to enable smart biotechnology [16]. As a result of these experimental and computational advances, 2D materials are explored in the landscape of biomedical applications such as bioimaging [17-19], drug delivery [18, 20–22], photothermal cancer therapy (PTT) [23-26], and tissue engineering (Fig. 1) [21, 27–29].
Figure 1
Schematic representation of synthesis and preparation, materials engineering, biomedical applications, and ML approaches applicable in 2D materials.
Schematic representation of synthesis and preparation, materials engineering, biomedical applications, and ML approaches applicable in 2D materials.In this review, we attempt to shed further light on significant advances and state-of-the-art development of van der Waals (vdW) materials, especially with regard to their applicability to biomedical applications. We first start our discussion with the general classification of 2D materials encompassing distinctive features such as optical, electronic, and structural properties, and synthesis protocols. Then, we present engineering methods for 2D materials applicable in various fields. Next, we present a thorough discussion of several biomedical applications that can benefit from 2D materials. After that, we include a brief discussion on the emerging role of ML in the efficient design of 2D materials and how different computational models can be beneficial in biomedical applications. Finally, we discuss the challenges and future prospects of 2D materials for next-generation biosensors and other biomedical applications. We believe that this comprehensive review will stimulate and trigger the understanding of 2D materials as a potential candidate in emerging biomedical applications.
Classification and properties of 2D materials
The blooming of nanotechnology attracts enormous research interest toward developing novel nanomaterials with one or more dimensions in the scale of nanometers. Their physical properties are not only defined by the chemical compositions, but also by their dimensionality. Among low-dimensional materials, 2D materials, characterized as nanosheets connected by weak vdW forces between layers, are well suited for biomedical applications because of their superior surface-to-volume ratio, facilitating surface adsorption of analyte molecules during biosensing. The response to the adsorption event can be further enhanced by surface functionalization and defect engineering that contributes to improving the sensitivity. Furthermore, the 2D nature allows different layered materials to be assembled and integrated, creating multifunctional medical devices. Their tolerance to mechanical strain up to 10% without rapture makes them a candidate for flexible skin electronics [30]. As the synthesis techniques advanced, wafer-scale 2D materials can be easily produced with high quality and uniformity that are compatible with scalable productions.2D materials are widely explored for optical biosensing including graphene and other carbonic materials like graphene oxide (GO) and reduced graphene oxide (rGO), BP, TMDs, BN, MXenes, etc. They cover a wide range of the optical spectrum from visible-to-near-infrared (NIR) region with tunable band gaps and contrasting optical and electronic properties (Table 1). For instance, graphene is a conducting material composed of carbon atoms in a hexagonal lattice. It possesses superior thermal and electrical conductivity leading to strong charge transfer, which is beneficial for sensing based on graphene-enhanced Raman spectroscopy [31]. The oxidation of graphene by the Hummers method produces graphene oxide (GO), which is also often used for improving the biosensing performance through fluorescence quenching [32]. Compared to semi-metallic graphene, the band gap of GO can reach up to around 3.5 eV depending on the degree of oxidation [33]. Its band gap can be further modulated by reducing GO to form reduced graphene oxide (rGO) of which band gap varies from 1.00 to 1.96 eV [34]. The engineering of band structure and related optical properties can also be realized by changing the number of layers for a wide range of 2D materials, for example, BP and TMDs. Unlike graphene, BP exhibits strong anisotropy in optical properties because of its unique crystal structures. The band gap of BP changes significantly from 0.3 to 1.59 eV from bulk crystals to monolayers because of band structure modulation [2]. It hosts strong optical absorptions in the IR regime and high carrier mobility up to 1000 cm2 V−1 s−1 [35]. In comparison, common TMDs monolayers have optical absorptions in the visible wavelength from 521 to 800 nm (2.38 to 1.55 eV) [36]. Besides, MXene is also an emerging type of 2D material that shows promise in optical biosensing [10]. It consists of layers of transition metal carbides, nitrides, or carbonitrides. The abundance of surface functionalization groups, such as –O, –OH, and –F, upon etching makes the surface adsorption of biological molecules easier to happen for MXenes [4]. Table 1 compares Crystal structures, bulk band gap, dielectric constant, and carrier mobility of different 2D materials.
TABLE 1
Crystal structures, bulk band gap, dielectric constant, and carrier mobility of different 2D materials.
2D material
Graphene
GO
BP
TMDs
h-BN
MXenes
Crystal structure(top and side views)
Bulk bandgap (1L bandgap)
0 eV
2.2 eV [34]
0.3 eV [2]
(2 eV) [37]
1.1–1.4 eV [38]
(1.6–2.4 eV) [39]
5.9 eV [40]
0–1.8 eV [41]
Dielectric constant at optical frequency
6.9 [42]
30–50 [43]
2.9 [44]
6.3–7.5 [45]
3.3 [45]
1–4 [46]
Carrier mobility
105 cm2/V s [47]
N/A
103 cm2/V s [37]
10–90 cm2/V s [48]
N/A
1–105 cm2/V s [49]
Crystal structures, bulk band gap, dielectric constant, and carrier mobility of different 2D materials.0.3 eV [2](2 eV) [37]1.1–1.4 eV [38](1.6–2.4 eV) [39]The practical application of 2D materials in biomedical applications is also enabled by the advances in producing large-area high-quality 2D materials. Chemical vapor deposition (CVD) and metal–organic CVD (MOCVD) are prevalent methods to synthesize wafer-scale 2D materials beyond graphene [50, 51]. Efforts have been made toward ensuring the uniform orientation and increasing the size of the domains, of which mechanism is guided by thermodynamics and kinetics [52]. In contrast, molecular beam epitaxy utilizes high-purity elemental sources and ultrahigh vacuum. The in situ characterizations in MBE offer better control of the number of layers compared with CVD [53]. It is also worth noting that 2D monolayers with a size up to millimeters have been realized by mechanical exfoliation using adhesive layers that show better chemical affinity with the 2D materials [54-56].
Surface and structural engineering of 2D materials
The rapidly expanding family of vdW materials with unique optoelectronic properties has remodeled the future of health-relevant sensing modalities. Achieving precise control over the surface chemistry of 2D materials is key for guaranteeing high standards in biomedical applications. Recent works have demonstrated unique engineering approaches including surface functionalization, doping, defect and strain engineering, multilayer stacking, and incorporating with plasmonic nanoparticles, quantum dots (QDs), and functional polymers to broaden the scope of biomedical applications by creating devices with enhanced performance. Here, we briefly highlight the above 2D material engineering pathways for utility in biomedical applications.
Surface functionalization
Surface functionalization can be used to endow properties such as stability and biocompatibility for multifunction capacity. Pristine 2D materials are rarely used in biomedical applications due to the lack of targeting ability. Functionalization strategies have been well accepted to introduce colloidal stability and biocompatibility in order to fuel biomedical applications. Graphene as a widely explored material can be functionalized at the basal plane and edges. Typically, for graphene, π–π interactions can facilitate the interface between the basal plane and foreign molecules, while edges with dangling bonds can form strong interactions with biomolecules [57]. GO is characterized by abundant reactive groups such as carboxylic acid groups, hydroxides, and epoxides which are biocompatible, allowing efficient coupling with biomolecules, biological cells, and tissues. In this context, various biosensors can be developed based on the fact that surface functionalization could lead to changes in the charge density, electronic mobility, and mechanical strain [58]. Toward this goal, modification of GO by polyethylene glycol (PEG) has been widely utilized in targeted applications (Fig. 2a) [18, 21, 59]. Similar strategies can be extended for the surface modification of rGO as well as nanoparticles (NPs) decorated GO and rGO. Other functional groups, including poly-l-lysine (PLL) [60] and chitosan [20], have been explored as suitable candidates for the surface functionalization of GO [Fig. 2(b)].
Figure 2
Schematic representation of surface functionalization in 2D materials. (a) PEGylation of GO by PEG stars. Adapted with permission from Reference [18]
The existence of defect states in 2D materials has proved to enhance the catalytic activity, improve the optical properties of layered materials [79], and improve the sensitivity and selectivity of biosensors. Both defect and strain engineering can contribute to such defect states in 2D materials. Defect engineering can be achieved by introducing intrinsic defects (vacancy, active edge sites, etc.) and dopants (metal dopant, heteroatom dopant, etc.). Introducing crystalline imperfections into 2D materials is commonly achieved by electron or ion irradiation [80-83], plasma treatment [84], and thermal treatment [Fig. 3(a)–(d)] [85-87]. Focused ion beam (FIB) is a decent way to realize controllable density and distribution of defects. Both chalcogen and metal vacancies and even nanopores can be created in thin TMDs flakes by FIB [88]. Plasma treatment is a more macroscopic means of defect creation by surface modification, introducing doping as well as layer thinning [89]. Atomic-scale defects in WS2 and MoS2 arise after exposure to Argon plasma, resulting in a new defect-related photoluminescence (PL) peak at ~ 0.1 eV lower than the intrinsic A-exciton emission [90]. Thermal treatment under a particular atmosphere can also introduce a controllable number of defects and has the advantage of high throughput [85, 86, 91].
Figure 3
Illustration of structural-engineering approaches. (a) Schematic illustration of defect state in WSe2 monolayer. Adapted with permission from Reference [83]
The large surface-area-to-volume ratio of 2D materials makes them perfect candidates for biomedical applications. Furthermore, by integrating with other nanomaterials, it is possible to tailor the materials' electrical, optical, and other properties, giving rise to more possibilities of biomedical application. 2D heterostructures, which are assembled layer-by-layer from certain 2D materials, provide more possibilities of achieving better performing biosensors. Loan et al. fabricated a MoS2-graphene heterostructure with an ultrahigh sensibility of DNA molecules [Fig. 3(e)] [101]. Zeng et al. proposed a surface plasmonic resonance (SPR) system consisting of graphene-MoS2 heterostructure and an additional layer of gold (Au) [Fig. 3(f)] [102].2D materials nanocomposites are also proved to have enhanced analytical performance in biomedical applications [103]. Metal-structure-decorated 2D material composites improve the biosensing capabilities of electrochemical biosensors, benefited from the biocompatibility of the metal structures such as AuNPs and their ability to immobilize biological recognition elements as well as facilitated electron and mass transfer [104]. Metal-ion-doped 2D nanoflakes show the potential of realizing PTT and enhancing radiation therapy for tumor treatment [Fig. 3(g)] [105]. Li et al. reported tin disulfide (SnS2) decorated with Au or bimetallic Pt–Au NPs results in larger current responses compared to the pristine ones in the amperometric glucose biosensor [106]. Currently, the biomedical applications of 2D vdWs still have many obstacles, for example, device mass production, durability, cost, etc. And there is still a lack of thorough understanding of the interaction mechanism of chemicals and biomolecules at 2D interfaces.
Biomedical applications of 2D materials
Various 2D materials have been investigated and examined for a wide variety of biomedical applications due to their excellent chemical and physical properties. The rationale behind using these materials in the biomedical field lies in the unique features that these materials offer, such as atomic-thin structure, broad surface area, the abundance of chemically active sites, large number of surface contacts, and quantum confinement effect, to name a few. Additionally, chemical and optical properties play a critical role in respective applications. On the other hand, interactive characteristics between 2D materials and biomolecules such as hydrogen bonding, electrostatic interactions, and hydrophobic interactions serve as driving forces to determine biological functions. In this section, we focused on representative biomedical applications of 2D materials.
Bioimaging
Bioimaging is an important field in research and clinical applications allowing visualization and monitoring of biological processes with the help of optical properties of materials. This is especially important in theranostics to ensure proper identification of tissues before treatments are started. In most cases, organic dye molecules were used as probes due to their high quantum efficiency, but they suffer from photobleaching, calling for alternative approaches. In this avenue, nanomaterials have proven their efficacy in bioimaging, and 2D materials are also researched heavily as a potential metal-free candidate in various bioimaging modalities. Apart from multicolor fluorescent imaging, other imaging platforms such as photoacoustic imaging (PA), magnetic resonance imaging (MRI), computed tomography imaging (CT), surface-enhanced Raman scattering (SERS) imaging, positron emission-computed tomography imaging (PET), and multimodal imaging techniques are significantly improved for the understanding of various cellular activities and functions as well as monitoring of internal body structures. In this section, 2D material-based bioimaging applications are briefly discussed.CT imaging is one of the most routinely applied techniques, which relies on the difference in contrast between lesions and tissues to reconstruct the cross-sectional images. Among the 2D-layered material family, TMDs and MXenes are ideal candidates for CT imaging as compared to carbon-based materials due to the high atomic-number elements that can provide excellent X-ray attenuation ability. Therefore, it is essential to use functionalized graphene to realize graphene-based 2D materials in CT imaging. For example, the application of GO as a contrast agent in CT was demonstrated with the Au microcapsule deposition technique [107]. Here, AuNPs were served as a contrast agent to enhance CT imaging while GO serves as a better absorber in the NIR range for PTT. Particularly, PEGylated WS2 nanosheets were demonstrated as a bimodal contrast agent for enhanced X-ray CT and PA tomography (PAT) bimodal imaging of tumors [17]. As PAT imaging is based on acoustic detection of optical absorption, PEG-WS2 nanosheets with high NIR absorbance appear to be an ideal contrast agent providing uniform signal distribution inside the tumor structure. Additionally, elaboratively designed nanocomposites such as BSA-coated WS2 [72] and PEGylated MoS2/Bi2S3 [108] also demonstrated strong X-ray attenuation, providing sensitive CT-imaging capability. Other 2D family members such as MXenes and BP were also investigated as desirable candidates for PA contrast agents. For example, SP-modified Ti3C2 nanosheets (Ti3C2-SP) were prepared by Han and coworkers, demonstrating multiple functionalities [78]. They found that Ti3C2-SP has high PA signal under 808 nm light irradiation and displayed a substantial increase in signal with increasing concentration of Ti3C2-SP. Furthermore, the PA-imaging capability of nanocomposite was illustrated with 4T1 tumor-bearing mice. The collected data suggested enhancing the PA contrast in the tumor within 4 h followed by the decay of the signal indicating gradual accumulation and excretion of Ti3C2-SP, further implying high biosafety for clinical applications. Recent work has been performed to advance the use of PA imaging in the NIR-II (1000–1700 nm) window in addition to the NIR-I (700–950 nm) window [109]. Apart from MXenes, Yang et al. developed modified BP nanosheets via π–π stacking strategy, opening window for a series of applications [63]. In particular, modified nanosheets showed excellent in vivo PA-imaging signals in the tumor.PET is another imaging technique based on detecting gamma rays as a result of introducing radiotracers into the body. Some engineering-designed 2D materials, such as graphene-based derivatives and TMDs were reported as key contrast agents [110, 111]. In a demonstration by Dong et al., a multifunctional MoS2-based nanoplatform was synthesized by decorating with hyaluronic acid (HLA) and polyethyleneimine (PEI), which is applicable in PET imaging of MCF-7-ADR tumor in mice [110]. They successfully labeled the nanocomposite with 64Cu to realize PET imaging of the tumor-bearing mice. In another work, Liu and coworkers uncovered the potential of radiolabeled MoS2-iron oxide (MoS2-IO) to enable PET imaging [112]. Utilizing radiolabeling, these researchers successfully demonstrated tumor accumulation of the nanocomposite. In another work, the same research group reported iron selenide (FeSe2) decorated bismuth selenide (Bi2Se3) nanosheets, revealing the applicability of TMDs as sophisticated bioimaging modalities for disease diagnosis [113]. Apart from TMDs, graphene-based derivatives were found immensely useful in PET imaging. Recently, Cai and coworkers reported 64Cu radiolabeling of GO taking advantage of interactions between Cu and the π electrons of GO [111]. Traditional radiolabeling strategies involved chelator conjugation (DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) or NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid)) as an essential step. But with this novel approach, researchers were able to preserve the pharmacokinetics of GO. In addition, they explored the labeling yield of PEGylated rGO and found out that it is superior to GO mainly due to the high concentration of π electrons in rGO. They demonstrated that this novel platform could provide informative results in PET imaging when tested on 4T1 breast tumor-bearing mice as shown in Fig. 4(a). Moreover, Kai and coworkers used 66Ga-labeled PEG-linked nGO for tumor-targeted PET imaging [114]. Overall, the presence of heavy elements and higher PT conversion efficiency established versatile 2D-layered materials as rising stars in CT and PAT imaging, respectively.
Figure 4
Different bioimaging modalities applicable in 2D materials. (a) Serial coronal PET images at different time points post-injection of 64Cu-RGO-PEG, 64Cu-NOTA-PEG-RGO, and (64Cu-NOTA)-rGO-PEG acquired in 4T1 tumor-bearing mice. Adapted with permission from Reference [111]
Many nanoplatforms have been employed for targeted drug delivery using NPs loaded with drugs to increase the local concentration of the drug at the target site and minimize any side effects. 2D materials, due to their atomic thickness and high specific surface area, are excellent candidates for targeted drug delivery. The ample surface enables drugs and other molecules to efficiently anchor on the surface and get delivered to the target site [128, 129]. Graphene and its derivatives, including GO and rGO, were among the first 2D materials to be explored as drug delivery carriers due to their surface properties, including delocalized π electrons on the surface enabling cancer drugs to anchor using π–π interactions [18, 22]. It also allowed the surface functionalization of the graphene surface, especially in GO and rGO, enabling drug loading by means of covalent bonding. GO has much broader applications in drug delivery due to the presence of the hydroxy and epoxide functional groups enabling efficient physisorption or chemisorption of drugs with high biocompatibility and stability [130]. These materials are often loaded with drugs like doxorubicin (DOX), a chemotherapy drug which slows down the growth of cancer cells, to evaluate their drug delivery attributes.Recently, Huang et al. prepared silicon contact lenses loaded with GO and HLA, a drop solution used to treat dry eye syndrome, with sustained release of HLA up to 96 h. The lenses were safe in an ocular irritation study with increased water retention preventing dry eyes [131]. A GO-sodium alginate (SA) composite was formed using Ca2+ as the crosslinker to prepare a freeze-dried SA-CA2+-GO hybrid which functioned as a drug carrier for methotrexate (MTX), as shown in Fig. 5(a). This hybrid carrier showed superb electro and pH-responsive release of MTX due to the excellent conductivity of GO and pH response of SA, respectively [132]. Further functionalization of GO and rGO is a great method to improve its biocompatibility and the choice of drugs to be delivered [133]. A multifunctional rGO hybrid can be created by reacting rGO with dopamine (DA), auric chloride, sodium borohydride (NaBH4), and DOX successively to create an rGO/DA/AuNP/DOX hybrid nanomaterial [134]. The nanomaterial displayed a pH-dependent DOX release with an initial loading capacity of 0.852 mg/mg of rGO/DA/AuNP/DOX material and PT properties, as shown in Fig. 5(b). Functionalized GO has also been used as a therapeutic nanomaterial against Parkinson’s disease (PD) by loading with Puerarin (Pue). This natural anti-PD compound otherwise cannot be used by itself due to its inadequate bioavailability and limited transfer through the blood–brain barrier (BBB) [135]. They created a Pue-loaded GO nanosheets with excellent drug-loading ability and biocompatibility, which crossed the BBB using lactoferrin as the targeting ligand [Fig. 5(c)]. In vitro and in vivo studies in mice proved this hybrid drug delivery system as an effective therapy for PD. These examples highlight the use of GO and rGO as excellent nanocarriers for drug delivery applications.
Figure 5
Different drug and gene delivery pathways based on 2D materials. (a) Schematic illustrating the making of MTX-loaded SA-CA2+-GO hybrids. Adapted with permission from Reference [132]
Gene delivery is an alternate approach to traditional treatments for genetic diseases and involves replacing the improperly functioning and disease-causing genes with new nucleic acid polymers, which function correctly and, thus, prevent the development of genetic diseases [139, 140]. Tremendous research efforts have been applied to develop gene delivery therapy for viral, cardiovascular, cancer, Parkinson’s, and other genetic diseases [141, 142]. This approach requires genetic material and a gene delivery agent which can protect the genes from lysosome degradation and deliver them to the target site while being non-toxic and non-immunogenic. Thus, the genetic material, i.e., DNA and RNA, needs to be encapsulated by the gene delivery agent through electrostatic interactions [143]. This therapeutic approach involves the use of siRNA (small interfering RNA), which regulates the expression of pathogenic proteins by destroying the target messenger RNA (mRNA), and this approach is termed RNA interference (RNAi) [144]. NPs and 2D materials can act as effective carrier agents for siRNA due to their large surface area, ability to functionalize their surface, and biocompatibility.Free nucleic acids are very fragile; they decompose quickly and have limited absorption due to their negative charge. GO also has a negative charge due to the presence of carboxyl groups on its surface. Thus, to effectively utilize GO as a gene carrier agent, it needs to be functionalized by positively charged polymers like PEI and PEG [145]. PEI-rGO hybrids have been shown to form complexes with siRNA using the gel electrophoresis method and have since become an excellent platform material for gene silencing [146]. Yin et al. prepared PEGylated GO nanosheets for PT and gene delivery for pancreatic cancer [147]. The authors used the multifunctionalized GO nanosheets to deliver HDAC1 and k-Ras siRNAs to target a specific pancreatic cancer cell MIA PaCa-2 in mice. They could silence both the HDAC1 and k-Ras genes, leading to cell growth inhibition in treated cancer cells. Further, combining NIR light PT with gene delivery led to an 80% reduction in tumor growth compared to untreated samples, as shown in Fig. 5(f) and (g). GO could also be easily metabolized in the mouse without any side effects.BP is another 2D material that has been utilized for gene delivery applications due to its high loading capacity, biocompatibility, and biodegradability. Yin et al. first used BPQDs-based nanocarriers functionalized with polyelectrolyte polymers (eg-poly(allylamine hydrochloride) (PAH)) to deliver siRNA into human ovarian cancer cells (eg-PA-1) [148]. The BP-PAH complex showed superior transfection efficiency with significant LSD1 (lysine-specific demethylase 1) mRNA suppression in PA-1 cells. BPQD possessed low cytotoxicity even at higher concentrations and inhibited the tumor growth by 80% in combination with NIR phototherapy. The scheme for the experiment is shown in Fig. 5(h). BP nanosheets have also been used for the delivery and release of CRISPR/Cas9 ribonucleoprotein to the cytoplasm for in vivo and in vitro genome editing and genome silencing [61].Protein therapy utilizes the delivery of precisely structured proteins to target sites with well-known biological effects and is an alternative form of treatment to gene delivery. Similar to gene therapy, the proteins used here are unstable with a short lifespan and need a suitable carrier to succeed as a therapeutic. Rebekah et al. developed a magnetic nanoparticle composite as a carrier for bovine serum albumin (BSA) protein [12]. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) analysis of Fe-GO-BSA and Fe-GO-CS-BSA solution showed no change after exposing them to trypsin for 3 h, thus, indicating that the protein remained intact, and the carrier protected it from enzymatic cleavage. More research is needed in engineering less cytotoxic and high drug-loading 2D materials hybrid for their use as nonviral vectors for gene and protein delivery.
Photothermal cancer therapy
Cancer is one of the deadliest diseases worldwide. Therefore, early diagnosis and treatment of this devastating disease are of paramount importance in medicine. Conventional treatments include chemotherapy, radiotherapy, hormonal therapy, immunotherapy, and surgery, but their long-term success rate is prohibited by efficacy and side effects on normal tissues. Due to these drawbacks researchers and medical professionals have made tremendous innovations based on alternative approaches such as nanomaterial-based therapies. PTT has advanced rapidly as a novel technique with a unique mechanism of cancer therapy. Briefly, this involves the conversion of light to thermal energy after exposure to a suitable PT agent to NIR radiation. This triggers the death of cancer cells while showing minimal invasiveness to normal tissues or cells. Many nanomaterials have effective light to heat conversion efficiency, and emerging 2D materials are also investigated as influential candidates. Such an interest in 2D materials is mainly due to their multifunctional potential ranging from tunable optical properties to ease of surface modification and plasmonic properties in the NIR region. Moreover, significant research interest is also devoted to designing 2D materials toward utilization in the NIR-II region compared to the widely studied NIR-I biological window. This is mainly due to higher power safety limits and desirable penetration depth into tumors buried deep in biological tissues [76]. Additionally, multiple imaging techniques can be employed to achieve better therapeutic efficacy of PTT. Another research area is integrating multifunctional nanomaterials with 2D materials for combined therapies such as PTT-Photodynamic therapy (PDT), PTT-Chemotherapy, and PTT-Immunotherapy to eliminate cancer cells. Herein, we summarize recent research progress of layered materials in the field of PTT.Graphene and its family members, such as GO and rGO, have been actively examined in PTT-related applications due to strong optical absorption in the NIR region. In order to enhance the biocompatibility and dispersity of 2D materials, the grafting of layered materials with PEG is widely used. Gu and coworkers developed a GO-based nanocarrier by attaching bifunctional PEG followed by a furin-cleavable peptide for combined cancer treatment [149]. Here, PEG serves as a bridge between carboxylate GO and furin-cleavable peptides while improving the dispersity and stability of GO. Alternatively, attachment of other biomolecules and polymers is also utilized in the surface functionalization of graphene-related materials. For example, porphyrin functionalized GO (PGO) demonstrated higher stability in an aqueous medium as compared to GO and efficient PT conversion efficiency of ablating brain cancer cells [150]. Liu and coworkers demonstrated in vivo PTT of cancer by using nanographene sheets [59]. They observed a significant increase in PEGylated nanographene sheets temperature upon irradiation of 808 nm light at a power density of 2 W cm−2 with the relatively unchanged temperature of the water sample as a control. They were able to photoablate U87MG cancer cells in a mouse by this approach. To improve the GO-based PTT, GO can be reduced to form rGO. In this regard, Dai and coworkers developed a PEGylated reduced nano-GO (nRGO) based PT agent exhibiting sixfold higher NIR absorption than nonreduced nano-GO (nGO) for eradicating cancer [26]. Here, higher NIR absorption was attributed to partial restoration of aromaticity. Furthermore, they observed a concentration-dependent increase in temperature for nRGO and nGO where the former showed an increase in temperature more than 50 °C and later showed maximum temperature up to 36 °C. In another demonstration, Kim and coworkers prepared functionalized rGO-based nanotemplate (PEG-PEI-rGO) based on PEI and PEG and demonstrated its enhanced photothermally triggered cytosolic drug delivery of DOX [151]. Li et al. developed a unique strategy based on GO to dissociate amyloid aggregation which is beneficial in the treatment of Alzheimer’s disease [152]. This was observed by using thioflavin-S (ThS)-modified GO to generate heat for the dissociation of amyloid. All these findings highlight the necessity of careful material design to achieve better dispersity and stability of graphene-related materials with the ultimate goal of achieving higher PT efficiency.2D BP also has unique properties to determine its applicability in PTT. One of the drawbacks of BP is its intrinsic instability due to the high reactivity of oxygen and water, hindering its applications. Several efforts have been employed to tackle this issue, and surface modification appears to be among the best to enhance the PT performances of bare BP. In a pioneering work by Mei and coworkers, polydopamine (PDA) modification was applied on bare BP to synthesize a novel multifunctional co-delivery system for targeted gene/chemo/PTT [153]. Briefly, permeability glycoprotein siRNA (P-gp siRNA) was adsorbed to the surface of BP, followed by DOX loading. Then, that system was grafted by PDA followed by decorating with an aptamer (NH2-PEG-Apt) to achieve active tumor targeting capacity while providing excellent physiological stability. PDA-modified BP showed enhanced PT activity based on temperature changes upon NIR laser irradiation. Incredibly, there was a minimum indication of degradation of PT performances even after 3 days exhibited by PT heating curves. Additionally, the hybrid system was beneficial in targeted chemo and gene delivery. Zhao et al. introduced Nile Blue dye to BP (NB@BPs) through diazonium chemistry and found that surface-modified BP exhibit NIR fluorescence enabling NIR imaging-guided PTT [62]. NB@BPs and BP shows temperature rise of 23.5 and 11.5 °C confirming the superiority of NB@BPs as an efficient PT agent. This is further confirmed by shrink and complete tumor removal after 16 days [Fig. 6(c), (d)]. Mice with MCF7 cancer cells were used with 808 nm laser irradiation to evaluate the PT performances. On the other hand, integrating BP with different nanomaterials has become an attractive strategy to achieve satisfactory treatment. Inspired by that Hu and coworkers harvested a nanocomposite by integrating AuNPs, polypyrrole (PPy), and PEG with BP sheets (Au-BPS-PPy-PEG), illustrating excellent PT conversion efficiency and simultaneously improvement of reactive oxygen species (ROS) generation [23]. Here, higher ROS generation was attributed to the creation of Schottky barriers to inhibit electron recombination after incorporating Au, which is highly beneficial in sonodynamic cancer therapy. Additionally, the hybrid nanocomposite is benefited from the superior PT efficiency provided by PPy. Additional methods including atomic layer deposition of Al2O3, [154] SiO2 passivation [155], encapsulation with graphene and BN [156], coordination with titanium sulfonate ligand [157], Te doping [158], and edge selective functionalization with C60 molecules [159] have been proven to slow down the reactivity of BP toward oxygen and water.
Figure 6
Various applications of 2D materials in PTT. (a) Schematic illustration of synthesis and theranostic functions of MnO/Ta4C3–SP composite nanosheets. Adapted with permission from Reference [77]
Tissue engineering has emerged as a popular pathway to repair and regenerate damaged tissues using biocompatible engineering materials. Scaffolds created from nature-based materials and biopolymers have been utilized in the past due to their biocompatibility, but they have poor mechanical strength and degrade much faster [27]. 2D materials have emerged as potential candidates for tissue engineering applications in the past few years due to their unique physicochemical properties, biocompatibility, biodegradability, low cellular toxicity, and large surface area. These excellent properties have led to the utilization of these materials as scaffolds for bone tissue, cardiac tissue, neural tissue, skin tissue, and skeletal muscle regeneration [29].Surface morphology plays a vital role in the biocompatibility of a material and its potential use as biomaterials. Graphene and its derivatives like GO and rGO are crucial due to the presence of wrinkles on their surface, which increases the surface roughness allowing cells to attach to them easily [28]. The oxygen functional groups on GO can lead to the generation of oxidative stress, which destroys the outer cell membrane of E. coli [14]. Meanwhile, rGO showed higher antibacterial properties than GO due to its higher electrical conductivity. In both cases, the sharp edges of the nanosheets were thought to contribute to membrane stress which enhanced the antibacterial effect [14].An effective way to prevent infection and heal wounds is by using biocompatible scaffolds with tissue regenerative capabilities. Sheish et al. used the electrospinning method to synthesize polyvinylpyrrolidone-acrylic acid hydrogel (PVPA)–eggshell membrane (ESM) nanocomposites with different weight percentages of rGO nanosheets, as shown in Fig. 7(a) [164]. The rGO reduced the fiber diameter and increased the water permeability of fibers, which helped enhance the composite's water swelling ratio and biodegradability. The composite wound dressing with rGO also increased the PC12 cell viability compared to non rGO loaded PVPA-ESM nanofiber wound dressing, as shown in Fig. 7(b) [164].
Figure 7
Various tissue engineering applications in 2D materials. (a) Scanning electron microscopy images and frequency distribution of the fiber diameter for PVPA–ESM composites with no rGO, 0.5 wt% rGO, 1 wt% rGO, and 2 wt% rGO fibers, respectively. Adapted with permission from Reference [164]
Emerging role of machine learning toward 2D material-based biomedical applications
In recent years, ML is thriving in the fields of bioimaging, biosensing as well as other biomedical applications [16, 177–179]. ML algorithms including support vector machine (SVM), random forest (RF), convolutional neural network (CNN), etc. have been applied to various biosensing data analyses and can be easily extended to 2D material-based biomedical applications [Fig. 8(a) and (b)]. The most common application that ML methods are used in bioimaging and biosensing is classifying target analyte categories [16]. For example, ML classification of MRI images has been used to diagnose Alzheimer’s disease [180], brain cancer [181], heart disease [182], etc. Recently, Isamel et al. utilized CNN to classify 3 brain tumor types (Meningiomas, Gliomas, and Pituitary tumors) with MRI images [181]. They used ResNet50 and achieved 99% accuracy which is a state-of-the-art result that outperformed all previous works [183]. CT images have a similar data type and can also be fed into ML to detect cancers [184], viruses [185], etc. With the combination of ML and CT images, Barstugan et al. diagnosed COVID-19 disease and obtained 99% accuracy using the SVM classifier [186]. A recent study by Ye et al. used various ML models to classify respiratory viruses based on Raman-sensing data [187]. In addition, interpretable ML has been applied to understanding Alzheimer’s disease biomarkers based on 2D material-assisted Raman spectroscopy [120]. ML has greatly accelerated the analyses of different types of biosensing data. The merits of advanced ML assistance on biosensing can also be directly extended to other 2D material-based biomedical applications.
Figure 8
Illustration of applicability of ML in materials science and biomedical applications. (a) General process of ML-based data analysis. Adapted with permission from Reference [16]
In this article, state-of-the-art research works based on 2D-layered materials designed for biomedical applications have been systematically reviewed with a strong focus on surface engineering and benchmark biomedical applications. Graphene and other layered materials bring exciting new opportunities in biomedical applications such as drug delivery, cancer therapy, gene delivery, bioimaging, etc. The most fascinating feature of these layered materials is integrating multiple functions into a nanodevice to facilitate research and development. A variety of structural and surface engineering methods have been developed to manipulate properties of 2D-layered materials while maintaining their biocompatibility for expanding biomedical applications. Strain engineering and folding are the main 2D material structural-engineering paths allowing manipulation of optoelectronic properties. Defect engineering is proved to be an effective way for improving and modulating the biomedical performance of 2D-layered materials. Engineering approaches such as e-beam/ion/laser irradiation, plasma treatment, and substitutional doping have been utilized to introduce defects in the materials. Although great progress has been made in the past decades, many challenges and obstacles lack the investigation of 2D materials-based biomedical applications. First, there is an absence of a comprehensive understanding of the correlation between atomic-scale defects and optical or electronic properties of the materials. Second, introducing defects with precise control in distribution and density is still not yet achieved experimentally. Furthermore, characterization techniques and calculation interpretation are still evolving, which are also essential in utilizing defects in biomedical applications.Engineering of 2D materials, including the application of strain and assembling of various 2D materials into heterostructures, has been the key technology to manipulate structural properties. Application of strain in 2D materials provides a new degree of freedom of electronic band structure tuning, creating novel and exotic optical or electrical properties, which can be utilized in biomedical device design. 2D heterostructures enable another way to tailor material properties, leading to the design of better performing optical/electrical/biomedical nanodevices. Additionally, 2D materials can offer an easy and effective way of addressing the need for better device fabrication for biomedical applications by considering band alignments. A recent report suggested 2D vdWs heterostructures based on different band alignments are beneficial for a series of biomedical applications [196]. For example, BP-WSe2 heterostructure, which follows the type-I band arrangement, allows the transfer of electrons and holes from one material to another. This results in enhanced radiative recombination of carriers suitable for fluorescence bioimaging. They prepared WSe2/BP/WSe2 heterostructure after chemical treatment and surface modification. More importantly, the proposed heterostructure can emit NIR radiation and generates heat which is applicable in PTT. On the other hand, they proposed MoS2/WSe2 heterostructure with type-II band arrangement for cancer treatments benefiting from strong IR absorption and drug delivery applications. Therefore, the preparation of different 2D materials heterostructures satisfying type-I and type-II band arrangement could open a world of opportunities to revolutionize medical strategies.As surface functionalization provides great inspiration for scientists to develop materials for a range of applications, there should be continuous efforts dedicated to assembling 2D materials with NPs and QDs for clinical translation. Emerging functionalization strategies such as intercalation by metallic atoms or molecules should receive more attention as it is a great way to modify the band structure of 2D materials. One of the main obstacles in clinical transformation is the non-specific binding of non-target molecules toward biosensors which interferes with the accurate determination of the limit of detection. Therefore, developing functionalization strategies that inhibit non-specific binding is highly demanding. Another potential direction would be 2D material optical sensors based on SPR as a label-free technique for the rapid diagnosis of diseases. In this regard, attention should be oriented toward better sensor design with enhanced sensitivity, specificity, and reproducibility of detection.In parallel to developing better surface and structural-engineering platforms that respond to modern-day health care needs, this field needs to dive into ML approaches that can help understand and optimize 2D material synthesis pathways. Such methods will allow scientists in academia and industry to efficiently design 2D materials by avoiding time and cost associated with traditional empirical trial and error methods and the density functional theory. As toxicity is one of the barriers to using 2D materials in healthcare applications, ML approaches can be employed to study 2D material toxicity [197-200]. Additionally, there is a great capacity to use ML-assisted 2D material synthesis to explore structure–property relationships. Unlocking the true potential of ML in 2D material synthesis and corresponding applications will require concerted efforts from a broader community, as discussed in the article. We anticipate that realization of ML-assisted 2D material discovery would be a revolutionary step in transforming these materials into biomedical applications.So far, remarkable progress and excellent future opportunities are evident in this field while highlighting the growing need for better device fabrication and cost-effective manufacturing processes. The full utilization of 2D materials in clinical applications still requires ongoing efforts as the development of 2D materials for biomedical applications is still in its immature stage. For instance, the development of large-scale synthesis and engineering approaches to prepare layered materials with the highest purity while maintaining their size, shape, and charge is of paramount importance to achieve sensitive and controllable biosensing platforms. Additionally, research into new avenues of nanoscale optical engineering is expected to boost 2D material-based biomedical applications. Integrating materials science with computational approaches such as ML is a prerequisite to responding to the needs of modern healthcare applications. On the other hand, a better understanding of the biological behavior of 2D material inside living bodies is largely unknown, which presents a significant barrier in clinical applications. Therefore, substantial efforts should be aimed toward biosafety assessment with animal models to gain an in-depth understanding of immunomodulation, pharmacodynamics, and pharmacokinetic profiles of 2D nanomaterials and their heterostructures. This will enable the active targeting ability of 2D material-based theranostic agents. In order to have a competitive advantage over traditionally used nanocomposites, the commercialization of 2D materials faces another hurdle. Such limitations can be overcome by exploring the mass production of high-quality 2D materials. These developments are expected to lead to personalized medicine that can fill voids in modern health care through collaborations involving materials science, biomedical engineering, chemistry, and emerging ML pathways. The recent COVID-19 pandemic alerts us that better access to disease prevention, diagnosis, and treatment is highly demanded. In this regard, engineered 2D materials hold great promise in new sensing modalities that significant impact on medical diagnosis. Thus, exploring new avenues of 2D material-based biomedical applications will unlock the true potential of personalized medicine. Overall, the rapid development of materials science and ML capabilities is continuously pushing the boundaries of 2D materials-based biosensing and biomedical applications. We hope this review will open a new avenue to this burgeoning field.
Authors: K S Novoselov; A K Geim; S V Morozov; D Jiang; Y Zhang; S V Dubonos; I V Grigorieva; A A Firsov Journal: Science Date: 2004-10-22 Impact factor: 47.728